SCHEMBL9920951

SCHEMBL9920951

Cc1ccc(-c2ccc3ccc4c(-c5cc(-c6cccc7ccccc67)cc(-n6c7ccccc7c7ccccc76)c5)ccc5ccc2c3c54)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 1/20 0.41
MCL1 Q07820 2/20 0.37
BAD Q92934 2/20 0.37
ENPP3 O14638 1/20 0.36
ENPP1 P22413 1/20 0.36
MAOA P21397 2/20 0.35
ERBB2 P04626 1/20 0.35
CYP1A2 P05177 1/20 0.35
FYN P06241 1/20 0.35
ACHE P22303 1/20 0.35
AHR P35869 1/20 0.35
MAOB P27338 1/20 0.34
TUBB4A P04350 1/20 0.34
TUBB P07437 1/20 0.34
TUBA3C P0DPH7 1/20 0.34
TUBA1B P68363 1/20 0.34
TUBA4A P68366 1/20 0.34
TUBB4B P68371 1/20 0.34
TUBB3 Q13509 1/20 0.34
TUBB2A Q13885 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9921089 0.92 KDM4E (0.37) FLT3MCL1BADMAOAERBB2
SCHEMBL13872361 0.90 FLT3 (0.40) FLT3MCL1BADENPP3ENPP1
SCHEMBL9920950 0.90 ALDH1A1 (0.35) FLT3MAOAERBB2CYP1A2FYN
SCHEMBL9920967 0.89 AKR1C4 (0.37) MCL1ALDH1A1KDM4EATML3MBTL1
SCHEMBL9920783 0.89 AKR1C4 (0.39) FLT3ALDH1A1KDM4EATML3MBTL1
SCHEMBL9920740 0.89 AKR1C4 (0.37) MCL1ALDH1A1KDM4EATML3MBTL1
SCHEMBL9920970 0.89 L3MBTL1 (0.33) FLT3ENPP1MAOAERBB2CYP1A2
SCHEMBL9920973 0.89 L3MBTL1 (0.35) FLT3MCL1BADMAOAERBB2
SCHEMBL9920658 0.89 FLT3 (0.40) FLT3MCL1BADENPP3ENPP1
SCHEMBL9920736 0.87 L3MBTL1 (0.38) FLT3MCL1BADMAOAERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2463352-B1 Light emitting device material and light emitting device TORAY INDUSTRIES (JP) 2018-05-02 EP disclosed
US-20140061629-A1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2014-03-06 US disclosed
US-20140061629-A1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2014-03-06 US disclosed
EP-2463352-A2 Light emitting device material and light emitting device Toray Industries, Inc. (JP) 2012-06-13 EP disclosed
EP-2463351-A2 Light emitting device material and light emitting device Toray Industries, Inc. (JP) 2012-06-13 EP disclosed
US-20090096356-A1 Light-emitting device material and light-emitting device TORAY INDUSTRIES, INC. (JP) 2009-04-16 US disclosed
US-20090096356-A1 Light-emitting device material and light-emitting device TORAY INDUSTRIES, INC. (JP) 2009-04-16 US disclosed
EP-1942171-A1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2008-07-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090096356-A1 Light-emitting device material and light-emitting device PRMT9, CCNL2, MRPL9 FLT3 1013/4885MCL1 3530/4885BAD 4605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.